One important issue using cells as therapeutics is targeted delivery. Engineering cell surfaces to improve delivery efficiency is thus of great interest. Here we report a simple, efficient and effective way to modify the cell surface with target-specific ligands, i.e., DNA aptamers, while minimizing the effects on the modified cells. We demonstrated that after incubating with lipoaptamer probes (shown in expansion), immune cells (red) recognize cancer cells (blue) in the cell mixture, and kill cancer cells.
KeywordsDNA aptamer; cell modification; cell targeting; cell-based immunotherapy Cell-based therapy has shown considerable potential in treating diseases such as leukemia and osteoporosis. Certain types of cells, for instance killer lymphocytes that naturally attack cancer cells, are being studied for direct cancer treatment [1] . Other cells, like mesenchymal stem cells (MSC), can be genetically engineered to produce therapeutics in situ after delivery [2] . However, one important issue in cell-based therapy is the targeted delivery of cells in vivo, which not only improves therapeutic efficacy, but also minimizes side effects.In this regard, several approaches have been studied. A straightforward method involves physical delivery of cells to the site of interest, with the help of proper medical devices [3] . Other targeting strategies, including the use of native cell-homing machinery [4] and expression or coating of cells with targeting ligands, are under intensive study. Carbohydrates [5] , short peptides [6] and extracellular domains of cell membrane receptors [7] have all been used as targeting moieties.In recent years, oligonucleotide-based probes, termed aptamers, have been developed with the specificity and affinity required for diagnostic [8] and therapeutic applications [9] . Similar to antibodies, aptamers can specifically recognize a wide range of targets that vary from small molecules to cancer cells [8,[10][11][12] . However, they have additional properties that make Previously, our lab developed diacyl phospholipid-DNA conjugates [13] , and in this paper, we report the use of this lipid-DNA probe to modify cell surfaces for specific cell targeting. We hypothesized that aptamers would induce cellular adhesion upon spontaneous receptorligand binding in a manner that mimics the natural process of cell-cell adhesion. We used leukemia cell lines to demonstrate that aptamers anchored on the cell surface could act as targeting ligands that specifically recognize their target cells. Further, we explored the potential of this probe in adoptive cell therapy. Immune effector cells modified by the probe showed improved affinity, while remaining cytotoxic to target cancer cells. Our method of aptamer-mediated cell targeting is illustrated schematically in Figure 1a.To label the cell surface with aptamers, diacyl lipid-DNA aptamer conjugates were synthesized as previously described [13] . A membrane-anchored aptamer can be divided into three distinct segments ( Figure 1a). The first segment is an ap...